Patent details

EP3030251 Title: IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE

Basic Information

Publication number:
EP3030251
PCT Application Number:
US2014050333
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147527667
PCT Publication Number:
WO2015021376
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
French Title of Invention:
NIVEAUX D'EXPRESSION D'IMMUNOGLOBULINE COMME BIOMARQUEUR DE LA RÉPONSE INHIBITRICE DU PROTÉASOME
German Title of Invention:
IMMUNGLOBULIN-EXPRESSIONSNIVEAUS ALS BIOMARKER FÜR DAS ANSPRECHEN AUF EINEN PROTEASOM-HEMMER
SPC Number:

Dates

Filing date:
08/08/2014
Grant date:
24/10/2018
EP Publication Date:
15/06/2016
PCT Publication Date:
12/02/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/10/2018
EP B1 Publication Date:
24/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/08/2019
Expiration date:
08/08/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/10/2018
 
 

Name:
Onyx Therapeutics, Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:
KIRK, Christopher, J.
Address:
United States (US)

2

Name:
KWEI, Kevin
Address:
United States (US)

3

Name:
DEGENHARDT, Jeremiah
Address:
United States (US)

4

Name:
TUCH, Brian
Address:
United States (US)

5

Name:
LOEHR, Andrea
Address:
United States (US)

Priority

1

Priority Number:
201361863809 P
Priority Date:
08/08/2013
Priority Country:
United States (US)

2

Priority Number:
201361875954 P
Priority Date:
10/09/2013
Priority Country:
United States (US)

3

Priority Number:
201462005904 P
Priority Date:
30/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/145; A61K 38/05; A61K 38/07; A61P 35/02; G01N 33/574; C12Q 1/68;

Publication

European Patent Bulletin

Issue number:
201843
Publication date:
24/10/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages